INVESTMENT AGREEMENTInvestment Agreement • January 4th, 2022 • Aravive, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTMENT AGREEMENT (this “Agreement”) is made and entered into on January 3, 2022, by and among Eshelman Ventures, LLC, a North Carolina limited liability company (the “Investor”), Aravive, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Article IV and Article V, Fredric N. Eshelman, Pharm.D. (“Eshelman”).
